China Healthwise Holdings Limited (HKG:0348)

China Healthwise Holdings Income Statement

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	103.7	113.58	146.32	142.06	170.08	137.85
Revenue Growth (YoY)	-17.97%	-22.38%	3.00%	-16.48%	23.38%	-4.19%
Cost of Revenue	63.16	78.58	193.49	113.57	181.69	125.49
Gross Profit	40.54	35	-47.18	28.49	-11.61	12.36
Selling, General & Admin	44.53	55.45	65.4	66.87	64.17	64.67
Operating Expenses	44.53	55.45	65.4	66.87	64.17	64.67
Operating Income	-3.99	-20.45	-112.58	-38.39	-75.79	-52.31
Interest Expense	-10.41	-8.3	-8.99	-7.3	-6.41	-18.85
Interest & Investment Income	-	-	-	-	-	0.01
Other Non Operating Income (Expenses)	0.02	0.01	0.18	0.7	0	5.8
EBT Excluding Unusual Items	-14.38	-28.74	-121.39	-44.98	-82.19	-65.35
Gain (Loss) on Sale of Investments	13.25	-4.19	-10.34	-15.33	-15.3	-5.41
Asset Writedown	-2.24	-0.8	-0.32	-0.62	-3.24	-3.03
Other Unusual Items	-6.3	-6.3	-	4.53	0.15	0.86
Pretax Income	-9.66	-40.03	-132.06	-56.4	-100.58	-72.93
Income Tax Expense	0.54	0.25	2.5	-2.13	2.47	-3.65
Earnings From Continuing Operations	-10.2	-40.28	-134.56	-54.27	-103.05	-69.28
Earnings From Discontinued Operations	-	-	-	-	-	44.06
Net Income to Company	-10.2	-40.28	-134.56	-54.27	-103.05	-25.22
Net Income	-10.2	-40.28	-134.56	-54.27	-103.05	-25.22
Net Income to Common	-10.2	-40.28	-134.56	-54.27	-103.05	-25.22
Shares Outstanding (Basic)	770	770	770	770	770	775
Shares Outstanding (Diluted)	770	770	770	770	770	775
Shares Change (YoY)	-	-	-	-	-0.58%	-4.42%
EPS (Basic)	-0.01	-0.05	-0.17	-0.07	-0.13	-0.03
EPS (Diluted)	-0.01	-0.05	-0.17	-0.07	-0.13	-0.03
Free Cash Flow	5.39	3.12	14.3	-28.97	41.72	7.47
Free Cash Flow Per Share	0.01	0.00	0.02	-0.04	0.05	0.01
Gross Margin	39.09%	30.82%	-32.24%	20.05%	-6.83%	8.97%
Operating Margin	-3.84%	-18.01%	-76.94%	-27.02%	-44.56%	-37.95%
Profit Margin	-9.84%	-35.47%	-91.96%	-38.21%	-60.59%	-18.30%
Free Cash Flow Margin	5.20%	2.75%	9.77%	-20.39%	24.53%	5.42%
EBITDA	-3.71	-20.12	-112.2	-38.2	-75.48	-50.75
EBITDA Margin	-3.57%	-17.72%	-76.68%	-26.89%	-44.38%	-36.81%
D&A For EBITDA	0.28	0.33	0.38	0.18	0.31	1.56
EBIT	-3.99	-20.45	-112.58	-38.39	-75.79	-52.31
EBIT Margin	-3.84%	-18.01%	-76.94%	-27.02%	-44.56%	-37.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.